|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11,005.00 JPY | -0.14% |
|
+9.39% | +24.03% |
| 03-04 | Irlab Working to Secure Funding for Phase 3 Study of Mesdopetam - fc | FW |
| 02-26 | Irlab Receives $3 Million Milestone Payment Following Dosing in Phase 1b Study | FW |
| Capitalization | 5,809B 36.37B 31.85B 28.76B 27.5B 49.91B 3,363B 52.07B 344B 136B 1,610B 137B 134B | P/E ratio 2026 * |
20.1x | P/E ratio 2027 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise value | 5,337B 33.41B 29.26B 26.43B 25.27B 45.85B 3,090B 47.84B 316B 125B 1,480B 125B 123B | EV / Sales 2026 * |
2.12x | EV / Sales 2027 * | 2.01x |
| Free-Float |
81.22% | Yield 2026 * |
1.3% | Yield 2027 * | 1.39% |
Last Transcript: Otsuka Holdings Co., Ltd.
| 1 day | -0.14% | ||
| 1 week | +9.39% | ||
| Current month | +2.75% | ||
| 1 month | +3.97% | ||
| 3 months | +18.18% | ||
| 6 months | +29.38% | ||
| Current year | +24.03% |
| 1 week | 9,602 | 11,130 | |
| 1 month | 9,602 | 11,130 | |
| Current year | 8,671 | 11,130 | |
| 1 year | 6,465 | 11,130 | |
| 3 years | 3,913 | 11,130 | |
| 5 years | 3,827 | 11,130 | |
| 10 years | 3,224 | 11,130 |
| Manager | Title | Age | Since |
|---|---|---|---|
Makoto Inoue
CEO | Chief Executive Officer | 67 | 31/12/2024 |
Yuko Makino
DFI | Director of Finance/CFO | 64 | 28/02/2018 |
Masanori Udagawa
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Tatsuo Higuchi
BRD | Director/Board Member | 75 | 07/07/2008 |
Noriko Tojo
BRD | Director/Board Member | 62 | 19/08/2008 |
Yoshiro Matsuo
BRD | Director/Board Member | 65 | 07/07/2008 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.14% | +9.39% | +44.46% | +178.68% | 36.39B | ||
| -1.30% | +0.12% | +7.02% | +88.22% | 46.73B | ||
| -1.91% | +1.05% | +303.34% | +1,470.70% | 11.97B | ||
| -0.72% | -0.49% | -10.07% | +50.76% | 11.48B | ||
| -1.20% | -0.78% | +2.58% | +92.52% | 9.86B | ||
| -0.06% | +3.11% | +69.60% | +53.19% | 8.47B | ||
| +0.44% | 0.00% | +36.90% | +119.05% | 7.98B | ||
| +1.18% | -6.27% | +44.53% | -16.27% | 6.96B | ||
| -3.80% | +2.18% | +54.48% | +422.05% | 6.62B | ||
| +0.59% | +3.39% | +14.89% | +61.63% | 6.31B | ||
| Average | -0.69% | +1.53% | +56.77% | +252.05% | 15.28B | |
| Weighted average by Cap. | -0.78% | +2.58% | +46.71% | +223.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2,515B 15.74B 13.79B 12.45B 11.91B 21.6B 1,456B 22.54B 149B 58.93B 697B 59.12B 57.86B | 2,592B 16.23B 14.21B 12.84B 12.27B 22.27B 1,501B 23.24B 154B 60.75B 719B 60.95B 59.65B |
| Net income | 289B 1.81B 1.58B 1.43B 1.37B 2.48B 167B 2.59B 17.09B 6.76B 80B 6.78B 6.64B | 310B 1.94B 1.7B 1.54B 1.47B 2.67B 180B 2.78B 18.39B 7.28B 86.07B 7.3B 7.14B |
| Net Debt | -472B -2.96B -2.59B -2.34B -2.24B -4.06B -273B -4.23B -27.96B -11.06B -131B -11.1B -10.86B | -607B -3.8B -3.33B -3.01B -2.87B -5.22B -352B -5.44B -35.96B -14.23B -168B -14.28B -13.97B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/03/26 | 11,005.00 ¥ | -0.14% | 1,838,700 |
| 12/03/26 | 11,020.00 ¥ | +1.29% | 1,863,000 |
| 11/03/26 | 10,880.00 ¥ | +6.77% | 1,913,600 |
| 10/03/26 | 10,190.00 ¥ | +3.24% | 1,515,600 |
| 09/03/26 | 9,870.00 ¥ | -1.89% | 1,516,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4578 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















